Your session is about to expire
← Back to Search
AMPLATZER Device for Ventricular Septal Defects (VPA Trial)
VPA Trial Summary
This trial is designed to study the safety and effectiveness of the AMPLATZER Muscular VSD Occluder, which was approved by the FDA in 2007.
VPA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowVPA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.VPA Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a hole in my heart after a heart attack.I am considered high-risk for standard heart surgery due to my heart's structure.My overall health is stable.My heart defect is close to the heart valves.I weigh less than 5.2 kg.I currently have an active bacterial infection.I cannot take anti-platelet medications due to health reasons.I have a significant hole in the heart muscle wall that needs closing.My doctor thinks closing the hole in my heart is necessary.I have severe lung blood pressure issues and irreversible lung vessel disease.I have a hole in my heart near the aortic valve.I have an infection that has spread throughout my body.I have a significant heart shunt, high lung blood pressure, or symptoms of heart failure.
- Group 1: 1
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many sites are conducting this research trial?
"This trial is enrolling participants at various medical institutions, such as the University of Iowa Hospitals & Clinics in Iowa City, Iowa; Medical University of South carolina in Charleston, South Carolina; and BC Children's Hospital in Vancouver, British Columbia. Additionally there are 51 other sites that have been approved for recruitment."
Is recruitment currently ongoing for this clinical trial?
"The information on clinicaltrials.gov states that this particular research is no longer enrolling patients. The project was posted for the first time in March 2008 and last updated August 2022, with 11 other active trials available to prospective participants at present."
Share this study with friends
Copy Link
Messenger